Scientists identify how addictive drugs hijack natural reward processing

Mount Sinai Health System to Honor Dennis S. Charney, MD, Dean of the Icahn School of Medicine at Mount Sinai, for 18 Years of Leadership and Service at Annual Crystal Party

Discovery of Dopamine Receptors in a Previously Overlooked Part of the Brain Sheds Light on the Complex Circuitry for Anxiety and Depression

Eric J. Nestler, MD, PhD, Leading Brain Scientist and Interim Dean of the Icahn School of Medicine at Mount Sinai, Elected to the National Academy of Sciences

Mount Sinai Launches AI Small Molecule Drug Discovery Center

New Lipid Nanoparticle Platform Delivers mRNA to the Brain Through the Blood-Brain Barrier

Study Reveals New Way to Unlock Blood-Brain Barrier, Potentially Opening Doors to Treat Brain and Nerve Diseases

Mount Sinai Opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to Transform Health Care by Spearheading the AI Revolution

The proteins that drive drug addiction

Icahn School of Medicine at Mount Sinai Awarded $21 Million NIH Grant to Advance Understanding of Aging-Related Hormone

A Common Pathway in the Brain That Enables Addictive Drugs to Hijack Natural Reward Processing Has Been Identified by Mount Sinai